Immunological aspects of human leukaemia.
D000917:Antibody Formation; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D002471:Cell Transformation, Neoplastic; D003601:Cytotoxicity Tests, Immunologic; D000939:Epitopes; D005260:Female; D004854:Herpesvirus 4, Human / Q000276:immunology; D006649:Histocompatibility Antigens; D006801:Humans; D007106:Immune Sera; D007111:Immunity, Cellular; D007167:Immunotherapy; D007518:Isoantibodies; D007938:Leukemia / Q000276:immunology* / Q000628:therapy; D007962:Leukocytes / Q000276:immunology; D011247:Pregnancy; D011925:Rauscher Virus / Q000276:immunology; D012190:Retroviridae / Q000276:immunology; D013045:Species Specificity; D013601:T-Lymphocytes / Q000276:immunology
D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D000939:Epitopes; D006649:Histocompatibility Antigens; D007106:Immune Sera; D007518:Isoantibodies